Silicon Labs Q2 Revenue Reaches $228M as Non-GAAP EPS Surges 545% Amid Pending TI Merger
SLAB sits 89% above its 52-week low of $115.505.
Summary
Silicon Labs reported Q2 2026 revenue of $228 million, up 18% YoY, with non-GAAP EPS of $0.71, a 545% increase. Guidance was suspended due to the pending Texas Instruments acquisition.
Key Events · Earnings and Guidance · SLAB
-
Q2 Revenue Beats, Up 18% YoY
Revenue reached $228.19 million, driven by a 78% surge in Medical and 23% growth in Industrial & Commercial.
-
Non-GAAP EPS Soars 545%
Non-GAAP diluted EPS was $0.71, up from $0.11 a year ago, reflecting improved profitability and operating leverage.
-
Gross Margin Expands to 61.9%
Non-GAAP gross margin improved to 61.9%, up from 56.1% in Q2 2025, highlighting pricing power and product mix.
-
Guidance Suspended Due to TI Merger
Silicon Labs suspended forward-looking guidance because of the pending acquisition by Texas Instruments, adding uncertainty.
Analysis · SLAB · Manufacturing
A standout quarter saw revenue climb 18% year-over-year to $228 million, while non-GAAP EPS rocketed 545% to $0.71. Medical revenue set a record with a 78% jump, and gross margins held near 62%, underscoring strong operating leverage. Forward guidance, however, was suspended because of the pending acquisition by Texas Instruments, forcing investors to balance the company's standalone momentum against the merger overhang. The results validate the strategic value TI sees in the business, but the absence of an outlook introduces uncertainty.
At the time of this filing, SLAB was trading at $218.25 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $115.51 to $220.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.